ES8307775A1 - Un procedimiento para la preparacion de una sal cristalina, no higroscopica y soluble en agua de etilendiamina, monoetanolamina o dietanolamina del 1,1-dioxido de n-(2-piridil)-2-metil-4-hidroxi-2h-1,2-benzotiazin-3-carboxamida. - Google Patents

Un procedimiento para la preparacion de una sal cristalina, no higroscopica y soluble en agua de etilendiamina, monoetanolamina o dietanolamina del 1,1-dioxido de n-(2-piridil)-2-metil-4-hidroxi-2h-1,2-benzotiazin-3-carboxamida.

Info

Publication number
ES8307775A1
ES8307775A1 ES512723A ES512723A ES8307775A1 ES 8307775 A1 ES8307775 A1 ES 8307775A1 ES 512723 A ES512723 A ES 512723A ES 512723 A ES512723 A ES 512723A ES 8307775 A1 ES8307775 A1 ES 8307775A1
Authority
ES
Spain
Prior art keywords
salts
dioxide salts
benzothiazine dioxide
crystalline
crystalline benzothiazine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES512723A
Other languages
English (en)
Other versions
ES512723A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of ES8307775A1 publication Critical patent/ES8307775A1/es
Publication of ES512723A0 publication Critical patent/ES512723A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE SALES DEL 1,1-DIOXIDO DE N-(2-PIRIDIL)-2-METIL-4-HIDROXI-2H-1,2-BENZOTIAZIN-3-CARBOXAMIDA. CONSISTE EN LA REACCION DEL 1,1-DIOXIDO DE N-(2-PIRIDIL)-2-METIL-4-HIDROXI-2H-1,2-BENZOTIAZIN-3-CARBOXAMIDA CON ETILENDIAMINA, MONOETANOLAMINA O DIETANOLAMINA, AL MENOS EN CANTIDAD EQUIMOLECULAR DE LA BASE. LA REACCION SE LLEVA A CABO EN UN DISOLVENTE PROTICO POLAR, TAL COMO EL AGUA, O EN CLORURO DE METILENO, A UNA TEMPERATURA ENTRE 20 C Y 100 C. ESTOS COMPUESTOS TIENEN APLICACIONES FARMACOLOGICAS COMO AGENTES ANTIARTRITICOS NO ESTEROIDEOS.
ES512723A 1981-06-01 1982-05-31 Un procedimiento para la preparacion de una sal cristalina, no higroscopica y soluble en agua de etilendiamina, monoetanolamina o dietanolamina del 1,1-dioxido de n-(2-piridil)-2-metil-4-hidroxi-2h-1,2-benzotiazin-3-carboxamida. Granted ES512723A0 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26898081A 1981-06-01 1981-06-01
US06/367,067 US4434164A (en) 1981-06-01 1982-04-13 Crystalline benzothiazine dioxide salts

Publications (2)

Publication Number Publication Date
ES8307775A1 true ES8307775A1 (es) 1983-08-01
ES512723A0 ES512723A0 (es) 1983-08-01

Family

ID=26953436

Family Applications (1)

Application Number Title Priority Date Filing Date
ES512723A Granted ES512723A0 (es) 1981-06-01 1982-05-31 Un procedimiento para la preparacion de una sal cristalina, no higroscopica y soluble en agua de etilendiamina, monoetanolamina o dietanolamina del 1,1-dioxido de n-(2-piridil)-2-metil-4-hidroxi-2h-1,2-benzotiazin-3-carboxamida.

Country Status (27)

Country Link
US (1) US4434164A (es)
EP (1) EP0066459B1 (es)
KR (1) KR850001883B1 (es)
AU (1) AU529386B2 (es)
BG (1) BG37377A3 (es)
CA (1) CA1209571A (es)
DD (1) DD211560A5 (es)
DE (1) DE3260718D1 (es)
DK (1) DK149024C (es)
EG (1) EG15811A (es)
ES (1) ES512723A0 (es)
FI (1) FI74705C (es)
GB (1) GB2101589A (es)
GR (1) GR75476B (es)
HK (1) HK65386A (es)
HU (1) HU189586B (es)
IE (1) IE53160B1 (es)
IL (1) IL65917A (es)
MX (1) MX6984E (es)
MY (1) MY8700126A (es)
NO (1) NO157979C (es)
NZ (1) NZ200801A (es)
OA (1) OA07114A (es)
PH (1) PH17906A (es)
PT (1) PT74977B (es)
RO (1) RO84698B (es)
YU (1) YU42767B (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5913714A (ja) * 1982-07-13 1984-01-24 Taito Pfizer Kk 外用消炎鎮痛剤
RO88420A (ro) * 1983-04-25 1986-01-30 Pfizer Inc,Us Procedeu pentru prepararea unor saruri bazice de piroxican depuse pe suporturi farmaceutice
DE3431588A1 (de) * 1983-09-12 1985-04-04 Pfizer, Inc., New York, N.Y. Kristalline benzothiazindioxid-salze und diese enthaltende pharmazeutische zusammensetzungen
DE3346526C2 (de) * 1983-12-22 1986-12-11 A. Nattermann & Cie GmbH, 5000 Köln Pharmazeutisches Präparat zur therapeutischen Behandlung von rheumatischen Erkrankungen
IT1196307B (it) * 1984-10-22 1988-11-16 Chiesi Farma Spa Formulazioni farmaceutiche acquose di piroxicam monoidrato
US4582831A (en) 1984-11-16 1986-04-15 Pfizer Inc. Anti-inflammatory polymorphic monoethanolamine salt of N-(2-pyridyl)-2-methyl-4-hydroxy-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide compound, composition, and method of use therefor
US4559326A (en) * 1985-01-31 1985-12-17 Pfizer Inc. Antiinflammatory compositions and methods
US4623486A (en) * 1985-05-29 1986-11-18 Pfizer Inc. [4-substituted benzoyloxy]-N-substituted-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxides having anti-arthritic activity
US4610982A (en) * 1985-06-03 1986-09-09 Pfizer Inc. Anti-inflammatory benzo- and thieno-1,2-thiazine-3-carboxamide 1,1-dioxide derivatives, compositions, and method of use therefor
KR890001236B1 (ko) * 1985-10-02 1989-04-28 화이자 인코포레이티드 소염제 조성물의 제조방법
HU200926B (en) * 1988-10-28 1990-09-28 Egyt Gyogyszervegyeszeti Gyar Pharmaceutical composition comprising piroxicam and lactose for use in making tablets or capsules
IT1247492B (it) * 1991-04-18 1994-12-17 Francia Farma Sali ad attivita' antiinfiammatoria, antisettica, detergente e composizioni farmaceutiche
IT1283252B1 (it) * 1996-03-15 1998-04-16 Pulitzer Italiana Soluzioni di piroxicam iniettabili per via parenterale
GB0031107D0 (en) * 2000-12-20 2001-01-31 Glaxo Group Ltd Chemical compounds
FR2818641B1 (fr) * 2000-12-21 2004-03-05 Servier Lab Nouveaux derives de 1,1-dioxo-2h-1,2-benzothiazine 3-carboxamides, leur procede de preparation et les compositions pharmaceutiques que les contiennent
KR100446829B1 (ko) * 2002-02-20 2004-09-04 한국유나이티드제약 주식회사 가용화된 피록시캄을 함유한 확산형 정제의 조성물 및그의 제조방법
EP2792353B1 (en) 2003-05-22 2018-02-28 United Therapeutics Corporation Polymorph of Treprostinil diethanolamine salt
US20050176809A1 (en) * 2004-02-05 2005-08-11 Rodlen Laboratories, Inc. Method and compositions for treatment of painful disorders
EP1893190A4 (en) * 2005-04-28 2010-07-28 Theraquest Biosciences Llc METHODS AND COMPOSITIONS FOR TREATING PAIN
US8747897B2 (en) 2006-04-27 2014-06-10 Supernus Pharmaceuticals, Inc. Osmotic drug delivery system
EP2252570B1 (en) 2007-12-17 2017-04-05 United Therapeutics Corporation An improved process to prepare treprostinil, the active ingredient in remodulin ®
EP3209415B1 (en) 2014-10-20 2020-02-19 United Therapeutics Corporation Synthesis of intermediates for producing prostacyclin derivatives

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3591584A (en) 1968-08-27 1971-07-06 Pfizer Benzothiazine dioxides
US4074048A (en) 1976-05-10 1978-02-14 Warner-Lambert Company Process for the preparation of 4-hydroxy-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxides
US4100347A (en) 1976-06-10 1978-07-11 Pfizer Inc. 3,4-Dihydro-2-methyl-4-oxo-2H-1,2-benzothiazine-3-carboxylic acid-1,1-dioxide
DE2756113A1 (de) 1977-12-16 1979-06-21 Thomae Gmbh Dr K Neue 4-hydroxy-2h-1,2-benzothiazin- 3-carboxamid-1,1-dioxide, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
US4289879A (en) 1980-09-29 1981-09-15 Pfizer Inc. Synthetic method and intermediate for piroxicam

Also Published As

Publication number Publication date
MX6984E (es) 1987-01-19
NO157979B (no) 1988-03-14
IL65917A (en) 1985-08-30
NO157979C (no) 1988-06-22
DD211560A5 (de) 1984-07-18
EP0066459B1 (en) 1984-09-12
GB2101589A (en) 1983-01-19
IE53160B1 (en) 1988-08-03
KR850001883B1 (ko) 1985-12-28
NO821767L (no) 1982-12-02
HU189586B (en) 1986-07-28
DE3260718D1 (de) 1984-10-18
AU529386B2 (en) 1983-06-02
NZ200801A (en) 1985-01-31
EP0066459A1 (en) 1982-12-08
MY8700126A (en) 1987-12-31
FI74705C (fi) 1988-03-10
HK65386A (en) 1986-09-12
YU113782A (en) 1984-12-31
EG15811A (en) 1986-12-30
RO84698B (ro) 1984-09-30
FI821918A0 (fi) 1982-05-31
PH17906A (en) 1985-01-25
DK149024C (da) 1986-06-30
AU8432282A (en) 1982-12-09
IL65917A0 (en) 1982-08-31
CA1209571A (en) 1986-08-12
YU42767B (en) 1988-12-31
BG37377A3 (en) 1985-05-15
ES512723A0 (es) 1983-08-01
DK149024B (da) 1985-12-23
OA07114A (fr) 1984-03-31
RO84698A (ro) 1984-07-17
DK241682A (da) 1982-12-02
US4434164A (en) 1984-02-28
GR75476B (es) 1984-07-23
IE821286L (en) 1982-12-01
KR830010108A (ko) 1983-12-26
PT74977B (en) 1985-05-17
PT74977A (en) 1982-06-01
FI74705B (fi) 1987-11-30

Similar Documents

Publication Publication Date Title
ES8307775A1 (es) Un procedimiento para la preparacion de una sal cristalina, no higroscopica y soluble en agua de etilendiamina, monoetanolamina o dietanolamina del 1,1-dioxido de n-(2-piridil)-2-metil-4-hidroxi-2h-1,2-benzotiazin-3-carboxamida.
ES8304569A1 (es) Un procedimiento para la preparacion de una sal soluble en agua de lisina o arginina del 1,1-dioxido de n-(2-piridil)-2-metil-4-hidroxi-2h-1,2-benzotiazin-3-carboxamida.
PT87832A (pt) Process for preparing aromatic sulfonamides with a heterosycle fused useful as antiglaucoma agents
DE58909414D1 (de) Verpackungsmaschine zum Herstellen von Packungen.
FI853622A0 (fi) Diarylacetylener, deras framstaellning och anvaendning.
EG17391A (en) Process for preparing 2-(n-substituted guanidino)-4-heteroarylthiazole antiulcer agents
ES8707211A1 (es) Un procedimiento para la preparacion de derivados de dioxido de benzotiazina
DE59104611D1 (de) Vorrichtung zum Herstellen von Klappschachteln.
ES8701712A1 (es) Un procedimiento para la preparacion de una forma polimorfo i de una sal de monoetanolamina
ES524439A0 (es) Procedimiento de obtencion de los 2-amino 5- (aralcoil piperidino alcoil) amino 1,4-diazoles
AT375356B (de) Verfahren zum herstellen von neuen 5-(chlorphenyl)-6h-1,3,4-thiadiazin-2-aminen und von deren salzen
ES8801895A1 (es) Procedimiento para la obtencion de benzamidas
DE3887866D1 (de) Verpackungsmaschine zum Herstellen von Zigaretten-Packungen.
ES8506668A1 (es) Procedimiento de preparacion de nuevas sales de dioxido de benzotiacina.
PL236653A1 (en) Method of manufacture of novel salts of ethylenediamine,ethanoloamine or diethanolamine and n-/2-pyridyl/-methyl-4-hydroxy-2h-1,2-benzothiazinecarboxamide-3 1,1-dioxide
AU561308B2 (en) 2-(tolyl/cf3phenyl)-4-alkyl morpholines
ES541830A0 (es) Procedimiento para preparar derivados de guanidina
PT76077A (en) Process for preparing 6-aminoalkylpenicillanic acid 1,1-dioxides and derivatives as beta-lactamase inhibitors
YU72283A (en) Process for the manufcture of n-(2-pyrridyl)-2-alkyl-4-hydroxy-2h-1,2-benzothiazine-3-carboxamide-1,1-dioxide
YU191685A (en) Process for preparing n-(5-methyl-3-izoxalyl)-2h-1,2-benzothiazine-3-carboxamide-1,1-dioxide
YU42871B (en) Process for the manufacture of n-(2-pyridyl)-2-methyl-4-hydroxy-2h-1,2-benzothiazine-3-carboxamide-1,1-dioxide